Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Waugh

Showing results (151-160 of 207) with videos related to

Pageof 21
Sort By:
European Journal of Clinical Pharmacology|January 1, 1992
The sensitivity of human blood platelets to the aggregating agent ADP during different dietary sodium intakes in healthy menI F Gow, M Dockrell, C R Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2012
Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapyClare McCourt, Pamela Maxwell, Roberta Mazzucchelli, et al.
BMJ Open|June 19, 2021
Comorbidities do not limit improvement in pain and physical function after total knee arthroplasty in patients with knee osteoarthritis: the BEST-Knee prospective cohort studyLauren K King, Esther J Waugh, C Allyson Jones, et al.
Cancers|January 5, 2021
ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising RadiationConor Hanna, Victoria L Dunne, Steven M Walker, et al.
Carcinogenesis|May 20, 2008
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activationAngela Seaton, Paula Scullin, Pamela J Maxwell, et al.
The Journal of Experimental Medicine|October 7, 1997
Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor familyM A Degli-Esposti, P J Smolak, H Walczak, et al.
Molecular Pharmacology|March 23, 2000
Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonistsD F McCune, S E Edelmann, J R Olges, et al.
NAR Genomics and Bioinformatics|August 29, 2020
Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methodsRoss G Murphy, Aideen C Roddy, Shambhavi Srivastava, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2008
Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosisCatherine Wilson, Colin Purcell, Angela Seaton, et al.
Plos One|August 8, 2013
Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysisClare M McCourt, Darragh G McArt, Ken Mills, et al.
Pageof 21

Showing results (151-160 of 207) with videos related to

Sort By:
Pageof 21
European Journal of Clinical Pharmacology|January 1, 1992
The sensitivity of human blood platelets to the aggregating agent ADP during different dietary sodium intakes in healthy menI F Gow, M Dockrell, C R Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2012
Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapyClare McCourt, Pamela Maxwell, Roberta Mazzucchelli, et al.
BMJ Open|June 19, 2021
Comorbidities do not limit improvement in pain and physical function after total knee arthroplasty in patients with knee osteoarthritis: the BEST-Knee prospective cohort studyLauren K King, Esther J Waugh, C Allyson Jones, et al.
Cancers|January 5, 2021
ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising RadiationConor Hanna, Victoria L Dunne, Steven M Walker, et al.
Carcinogenesis|May 20, 2008
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activationAngela Seaton, Paula Scullin, Pamela J Maxwell, et al.
The Journal of Experimental Medicine|October 7, 1997
Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor familyM A Degli-Esposti, P J Smolak, H Walczak, et al.
Molecular Pharmacology|March 23, 2000
Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonistsD F McCune, S E Edelmann, J R Olges, et al.
NAR Genomics and Bioinformatics|August 29, 2020
Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methodsRoss G Murphy, Aideen C Roddy, Shambhavi Srivastava, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2008
Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosisCatherine Wilson, Colin Purcell, Angela Seaton, et al.
Plos One|August 8, 2013
Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysisClare M McCourt, Darragh G McArt, Ken Mills, et al.
Pageof 21